Real-world treatment patterns for patients with non-infectious uveitis in Japan: a descriptive study using a large-scale claims database (J-CAT study)

Abstract Purpose Non-infectious uveitis (NIU) can arise from various inflammatory disorders and can cause vision loss. Patients with mild NIU are typically treated with corticosteroid eye drops to reduce intraocular inflammation; however, other local/systemic treatments (corticosteroids, immunosuppr...

Full description

Saved in:
Bibliographic Details
Main Authors: Sentaro Kusuhara, Koh-Hei Sonoda, Toshikatsu Kaburaki, Tachie Fujita, Saki Katayama, Misako Makishima, Takao Nakamura, Mariko Nio, Takashi Omoto, Yukari Matsuo-Tezuka, Tomoki Yoshizaki, Kensuke Sasaki, Kairi Ri, Keiko Sato, Hiroshi Goto
Format: Article
Language:English
Published: SpringerOpen 2025-07-01
Series:Journal of Ophthalmic Inflammation and Infection
Subjects:
Online Access:https://doi.org/10.1186/s12348-025-00514-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849234742777479168
author Sentaro Kusuhara
Koh-Hei Sonoda
Toshikatsu Kaburaki
Tachie Fujita
Saki Katayama
Misako Makishima
Takao Nakamura
Mariko Nio
Takashi Omoto
Yukari Matsuo-Tezuka
Tomoki Yoshizaki
Kensuke Sasaki
Kairi Ri
Keiko Sato
Hiroshi Goto
author_facet Sentaro Kusuhara
Koh-Hei Sonoda
Toshikatsu Kaburaki
Tachie Fujita
Saki Katayama
Misako Makishima
Takao Nakamura
Mariko Nio
Takashi Omoto
Yukari Matsuo-Tezuka
Tomoki Yoshizaki
Kensuke Sasaki
Kairi Ri
Keiko Sato
Hiroshi Goto
author_sort Sentaro Kusuhara
collection DOAJ
description Abstract Purpose Non-infectious uveitis (NIU) can arise from various inflammatory disorders and can cause vision loss. Patients with mild NIU are typically treated with corticosteroid eye drops to reduce intraocular inflammation; however, other local/systemic treatments (corticosteroids, immunosuppressants, biologics) may be required for moderate-to-severe NIU, which may cause ocular complications. Here, we investigated real-world treatment patterns for NIU in Japan. Methods Patients were selected from a large, Japanese insurance claims database using International Classification of Diseases, Tenth Revision codes; diagnosis of NIU was confirmed via ophthalmological examination (October 2016–October 2023). Sankey diagrams were used to describe treatment transitions. Post-treatment ocular complications, potentially related surgeries, and fundus findings associated with uveitis were determined. Results The majority of patients (68.7%; 37,869/55,091) were treated with corticosteroid eye drops only for mild NIU; 19.0% (10,449/55,091) were given other treatments for moderate-to-severe NIU, mostly oral corticosteroids (7,473/10,449) and posterior sub-Tenon’s corticosteroid injections (1,636/10,449). In patients treated with corticosteroids orally or via sub-Tenon’s injections, common transitions were to corticosteroid eye drops or censor (end of treatment/dataset or insurance withdrawal). A higher incidence of treatment-related ocular complications and potentially related surgeries (including glaucoma) was observed during the first year of NIU treatment compared with subsequent years (for moderate-to-severe NIU, estimated incidence of prescription of glaucoma drugs was 106 per 1,000 person-years [at 1 year], 73 per 1,000 person-years [at 2 years], and 52 per 1,000 person-years [at 5 years]). Conclusion Our comprehensive analysis of a large claims database included all prescribed medications and medical procedures (including local injections) for NIU treatment in Japan up to October 2023. Although corticosteroids are a mainstay of NIU treatment in Japan, we found that a number of treatments for moderate-to-severe NIU, other than corticosteroid eye drops, are frequently used in combination with or when switching from corticosteroid eye drops. These findings are of importance when assessing the treatment landscape and may help identify unmet clinical needs in patients with NIU.
format Article
id doaj-art-06e974cbd6984cde90987c0cc05dba6d
institution Kabale University
issn 1869-5760
language English
publishDate 2025-07-01
publisher SpringerOpen
record_format Article
series Journal of Ophthalmic Inflammation and Infection
spelling doaj-art-06e974cbd6984cde90987c0cc05dba6d2025-08-20T04:03:02ZengSpringerOpenJournal of Ophthalmic Inflammation and Infection1869-57602025-07-0115111510.1186/s12348-025-00514-5Real-world treatment patterns for patients with non-infectious uveitis in Japan: a descriptive study using a large-scale claims database (J-CAT study)Sentaro Kusuhara0Koh-Hei Sonoda1Toshikatsu Kaburaki2Tachie Fujita3Saki Katayama4Misako Makishima5Takao Nakamura6Mariko Nio7Takashi Omoto8Yukari Matsuo-Tezuka9Tomoki Yoshizaki10Kensuke Sasaki11Kairi Ri12Keiko Sato13Hiroshi Goto14Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of MedicineDepartment of Ophthalmology, Graduate School of Medical Science, Kyushu UniversityJichi Medical UniversityChugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.Chugai Pharmaceutical Co., Ltd.Datack, Inc.Datack, Inc.Third Place, LLCDepartment of Ophthalmology, Tokyo Medical UniversityAbstract Purpose Non-infectious uveitis (NIU) can arise from various inflammatory disorders and can cause vision loss. Patients with mild NIU are typically treated with corticosteroid eye drops to reduce intraocular inflammation; however, other local/systemic treatments (corticosteroids, immunosuppressants, biologics) may be required for moderate-to-severe NIU, which may cause ocular complications. Here, we investigated real-world treatment patterns for NIU in Japan. Methods Patients were selected from a large, Japanese insurance claims database using International Classification of Diseases, Tenth Revision codes; diagnosis of NIU was confirmed via ophthalmological examination (October 2016–October 2023). Sankey diagrams were used to describe treatment transitions. Post-treatment ocular complications, potentially related surgeries, and fundus findings associated with uveitis were determined. Results The majority of patients (68.7%; 37,869/55,091) were treated with corticosteroid eye drops only for mild NIU; 19.0% (10,449/55,091) were given other treatments for moderate-to-severe NIU, mostly oral corticosteroids (7,473/10,449) and posterior sub-Tenon’s corticosteroid injections (1,636/10,449). In patients treated with corticosteroids orally or via sub-Tenon’s injections, common transitions were to corticosteroid eye drops or censor (end of treatment/dataset or insurance withdrawal). A higher incidence of treatment-related ocular complications and potentially related surgeries (including glaucoma) was observed during the first year of NIU treatment compared with subsequent years (for moderate-to-severe NIU, estimated incidence of prescription of glaucoma drugs was 106 per 1,000 person-years [at 1 year], 73 per 1,000 person-years [at 2 years], and 52 per 1,000 person-years [at 5 years]). Conclusion Our comprehensive analysis of a large claims database included all prescribed medications and medical procedures (including local injections) for NIU treatment in Japan up to October 2023. Although corticosteroids are a mainstay of NIU treatment in Japan, we found that a number of treatments for moderate-to-severe NIU, other than corticosteroid eye drops, are frequently used in combination with or when switching from corticosteroid eye drops. These findings are of importance when assessing the treatment landscape and may help identify unmet clinical needs in patients with NIU.https://doi.org/10.1186/s12348-025-00514-5CorticosteroidGlaucomaJapanNon-infectious uveitisTreatment patterns
spellingShingle Sentaro Kusuhara
Koh-Hei Sonoda
Toshikatsu Kaburaki
Tachie Fujita
Saki Katayama
Misako Makishima
Takao Nakamura
Mariko Nio
Takashi Omoto
Yukari Matsuo-Tezuka
Tomoki Yoshizaki
Kensuke Sasaki
Kairi Ri
Keiko Sato
Hiroshi Goto
Real-world treatment patterns for patients with non-infectious uveitis in Japan: a descriptive study using a large-scale claims database (J-CAT study)
Journal of Ophthalmic Inflammation and Infection
Corticosteroid
Glaucoma
Japan
Non-infectious uveitis
Treatment patterns
title Real-world treatment patterns for patients with non-infectious uveitis in Japan: a descriptive study using a large-scale claims database (J-CAT study)
title_full Real-world treatment patterns for patients with non-infectious uveitis in Japan: a descriptive study using a large-scale claims database (J-CAT study)
title_fullStr Real-world treatment patterns for patients with non-infectious uveitis in Japan: a descriptive study using a large-scale claims database (J-CAT study)
title_full_unstemmed Real-world treatment patterns for patients with non-infectious uveitis in Japan: a descriptive study using a large-scale claims database (J-CAT study)
title_short Real-world treatment patterns for patients with non-infectious uveitis in Japan: a descriptive study using a large-scale claims database (J-CAT study)
title_sort real world treatment patterns for patients with non infectious uveitis in japan a descriptive study using a large scale claims database j cat study
topic Corticosteroid
Glaucoma
Japan
Non-infectious uveitis
Treatment patterns
url https://doi.org/10.1186/s12348-025-00514-5
work_keys_str_mv AT sentarokusuhara realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT kohheisonoda realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT toshikatsukaburaki realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT tachiefujita realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT sakikatayama realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT misakomakishima realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT takaonakamura realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT marikonio realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT takashiomoto realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT yukarimatsuotezuka realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT tomokiyoshizaki realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT kensukesasaki realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT kairiri realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT keikosato realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy
AT hiroshigoto realworldtreatmentpatternsforpatientswithnoninfectiousuveitisinjapanadescriptivestudyusingalargescaleclaimsdatabasejcatstudy